clinical pharmacy

INTRODUCTION

Home care is a rapidly expanding and increasingly complex component of Canada’s health care system. This complexity can be attributed to a variety of factors, including aging of the population, de-institutionalization of health care delivery, increasing complexity of medical technology, and reduction in the number of informal care­givers for those requiring assistance in the home. Although many patients receiving home care services have complicated medication regimens, pharmacists have not traditionally been members of home care teams in Canada.

In its final report, the Commission on the Future of Health Care in Canada (the Romanow Commission) stated that one priority type of home care service to be included under the Canada Health Act is post-acute home care. This focus reflects recent medical literature demon­strating the increased risk of adverse events in the period immediately following a hospital stay. In fact, in their Canadian study, Forster and others found that 23% of medical patients experienced an adverse event within the first month after discharge from hospital, of which adverse drug events were the most common type, accounting for 72% of all adverse events. Therefore, intervention by pharmacists during this post-acute care period may help to minimize problems with pharmacotherapy, optimize medication regimens, and maximize medication safety. vardenafil 20 mg

Surprisingly, few descriptions or evaluations of the role of pharmacists in home care in Canada have been published. Indeed, MacKeigan and others found that the provision of clinical pharmacy services within the home care setting was uncommon in Canada. Researchers at the Institute of Health Promotion Research (University of British Columbia) have described the impact of home visits by pharmacists and nurses on patients recently (sur une echelle de 0 a 10) etait de 9,6 pour les membres de l’equipe de soins et de 9,9 pour les patients.